Inaktiver Wert

Andere Sprachen OXFORD BIOMEDICA Swiss Exchange

Aktien

Oxford Biomedica : Rules of the Oxford Biomedica 2024 Sharesave Scheme	15.05.
Oxford Biomedica : Rules of the Oxford Biomedica 2024 Long Term Incentive Plan	15.05.
Oxford Biomedica : Rules of the Oxford Biomedica 2024 Deferred Bonus Plan	15.05.
Oxford Biomedica : 2024 Notice of Annual General Meeting	15.05.
Oxford Biomedica : 2024 Notice of Annual General Meeting 15 May 2024	15.05.
Avon Protection wins UK MoD supply deal; Molten Ventures up	09.05.
Molten Ventures wins UK MoD supply contract	09.05.
NatWest target raised, other lenders backed	09.05.
Oxford Biomedica : Preliminary Results of the year ended 31 December 2023 29 April 2024	08.05.
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	03.05.
FTSE 100 as investors look to Fed rate decision	29.04.
Oxford Biomedica : Preliminary results for the year ended 31 December 2023 29 April 2024	29.04.
Oxford BioMedica bullish; Petrofac slumps	29.04.
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	29.04.
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	29.04.
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	29.04.
HSBC likes Haleon, cuts Flutter to 'hold'	18.04.
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	20.03.
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	20.03.
Oxford Biomedica plc Announces Board Changes	11.03.

Keine Ergebnisse zu dieser Suche